Trial intelligence / Profile preview

Bioequivalence of Metronidazole Benzoate Granules vs Flagyl Suspension and Tablets

NCT02146209Phase 1Completed

Sponsor
Verisfield
Start
Jun 2014
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of metronidazole benzoate in bacterial infection (3 arms), sponsored by Verisfield. Primary endpoint: Area Under the Curve. Started Jun 2014; status: completed.

02

Drugs

metronidazole benzoate
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT02146209.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02146209.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call